Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats

被引:5
|
作者
Choi, Hye D. [1 ,2 ]
Kang, Hee E. [1 ,2 ]
Chung, Hye J. [1 ,2 ]
Bae, Soo K. [1 ,2 ]
Shin, Karen N. [3 ]
Lee, Myung G. [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[3] NYU, New York, NY 10003 USA
关键词
theophylline; 1,3-DMU; pharmacokinetics; water deprivation for 72 h; CYP1A1/2,2B1/2 and 3A1/2; rats;
D O I
10.1002/bdd.573
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been reported that the expressions of hepatic microsomal cytochrome P450 (CYP) 1A1/2,2B1/2 and 3A1/2 were not changed in rats with water deprivation for 72h (rat model of dehydration) compared with the controls. It has been also reported that 1,3-dimethyluric acid (1,3-DMU) was formed from theophylline via CYP1A1/2 in rats. Hence, it could be expected that the formation of 1,3-DMU could be comparable between the two groups of rats. As expected, after both intravenous and oral administration of theophylline at a dose of 5 mg/kg to the rat model of dehydration, the AUC of 1,3-DMU was comparable to the controls. After both intravenous and oral administration of theophylline to the rat model of dehydration, the Cl-r of both theophylline and 1,3DMU was significantly slower than the controls. This could be due to significantly smaller urinary excretions of both theophylline and 1,3-DMU since the AUC of both theophylline and 1,3-DMU were comparable between the two groups of rats. The smaller urinary excretion of both theophylline and 1,3-DMU could be due to urine flow rate-dependent timed-interval renal clearance of both theophylline and 1,3-DMU in rats. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 50 条
  • [41] Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin
    Dong-Hyun Choi
    Jin-Seok Choi
    Cheng Li
    Jun-Shik Choi
    Pharmacological Reports, 2011, 63 (6) : 1574 - 1582
  • [42] Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects
    Shim, HJ
    Kim, YC
    Park, KJ
    Kim, DS
    Kwon, JW
    Kim, WB
    Lee, MG
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (11) : 2185 - 2195
  • [43] Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin
    Choi, Dong-Hyun
    Choi, Jin-Seok
    Li, Cheng
    Choi, Jun-Shik
    PHARMACOLOGICAL REPORTS, 2011, 63 (06) : 1574 - 1582
  • [44] Effects of E-coli Lipopolysaccharide on the Pharmacokinetics of Ipriflavone and Its Metabolites, M1 and M5, after Intravenous and Oral Administration of Ipriflavone to Rats: Decreased Metabolism of Ipriflavone Due to Decreased Expression of Hepatic CYP1A2 and 2C11
    Chung, Hye J.
    Kang, Hee E.
    Bae, Eun J.
    Lee, Inchul
    Kim, Sang G.
    Lee, Myung G.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (11) : 5024 - 5036
  • [45] Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats
    Lee, Chong-Ki
    Choi, Jun-Shik
    PHARMACOLOGY, 2010, 85 (06) : 350 - 356
  • [46] Physiologically based pharmacokinetic–pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans
    Wei-min Kong
    Bin-bin Sun
    Zhong-jian Wang
    Xiao-ke Zheng
    Kai-jing Zhao
    Yang Chen
    Jia-xin Zhang
    Pei-hua Liu
    Liang Zhu
    Ru-jun Xu
    Ping Li
    Li Liu
    Xiao-dong Liu
    Acta Pharmacologica Sinica, 2020, 41 : 852 - 865
  • [47] Physiologically based pharmacokinetic-pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans
    Kong, Wei-min
    Sun, Bin-bin
    Wang, Zhong-jian
    Zheng, Xiao-ke
    Zhao, Kai-jing
    Chen, Yang
    Zhang, Jia-xin
    Liu, Pei-hua
    Zhu, Liang
    Xu, Ru-jun
    Li, Ping
    Liu, Li
    Liu, Xiao-dong
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (06) : 852 - 865
  • [48] Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats
    Kim, YC
    Shim, HJ
    Lee, JH
    Kim, DS
    Kwon, JW
    Kim, WB
    Lee, I
    Lee, MG
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2005, 26 (07) : 309 - 320
  • [49] Stereoselective pharmacokinetics of 25-methoxyl-dammarane-3β,12β,20-triol and its active demethyl-metabolite epimers in rats after oral and intravenous administration
    Shao, Nan
    Jiang, Huan
    Wang, Xiaotong
    Yuan, Bo
    Jin, Yi
    Song, Mantong
    Zhao, Yuqing
    Xu, Haiyan
    FITOTERAPIA, 2017, 116 : 139 - 145
  • [50] The pharmacokinetics of 1954U89, 1,3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3,2-f)quinazoline, in dogs and rats after intravenous and oral administration
    Studenberg, SD
    Woolley, JL
    Deangelis, DV
    Wargin, WA
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1997, 18 (05) : 433 - 442